Original Article

You have full text access to this OnlineOpen article

Disease perceptions among people with Crohn's disease

  1. Sunanda V. Kane MD1,†,*,
  2. Edward V. Loftus Jr. MD1,‡,
  3. Marla C. Dubinsky MD2,§,
  4. Robert Sederman3,¶

Article first published online: 13 MAR 2008

DOI: 10.1002/ibd.20418

Issue

Inflammatory Bowel Diseases

Inflammatory Bowel Diseases

Volume 14, Issue 8, pages 1097–1101, August 2008

Additional Information

How to Cite

Kane, S. V., Loftus Jr., E. V., Dubinsky, M. C. and Sederman, R. (2008), Disease perceptions among people with Crohn's disease. Inflamm Bowel Dis, 14: 1097–1101. doi: 10.1002/ibd.20418

Author Information

  1. 1

    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

  2. 2

    Department of Pediatrics, Cedars Sinai Medical Center, Los Angeles, CA

  3. 3

    C1 Consulting, Summit, NJ

  1. †

    Dr. Kane has consulted for UCB Inc.

  2. ‡

    Dr. Loftus has received research support from and has consulted for UCB, Inc.

  3. §

    Dr. Dubinsky has received research support from and has consulted for UCB, Inc.

  4. Mr. Sederman is a consultant for UCB, Inc.

*MSPH, Mayo Clinic, 200 First St. SW, Rochester MN 55905

Publication History

  1. Issue published online: 11 JUL 2008
  2. Article first published online: 13 MAR 2008
  3. Manuscript Accepted: 14 JAN 2008
  4. Manuscript Received: 30 AUG 2007

Funded by

  • UCB Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (98K)

REFERENCES

  • 1
    Hanauer SB, Sandborn W. Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2001; 96: 635–643.
    Direct Link:
  • 2
    Sorenson VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut. 1987; 28: 383–385.
  • 3
    Drossman DA, Leserman J, Li Z, et al. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991; 53: 701–712.
  • 4
    Irvine EJ, Feagan BG, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994; 106: 287–296.
  • 5
    Casati J, Toner BB, de Rooy EC, et al. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci. 2000; 45: 26–31.
  • 6
    Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006; 4: 1491–1501.
  • 7
    Sands B, Siegel C, Hass S, et al. Crohn's disease patients' willingness to accept the risks of serious adverse events in exchange for clinical benefits. Digestive Diseases Week, May 20–25, 2006. Los Angeles, CA. Abstract W1200.
  • 8
    Siegel CA, Levy C, Mackenzie TA, et al. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Am J Gastroenterol. 2006; 101(9 Suppl): S438.
  • 9
    Hommes D, Baert F, van Assche G, et al. Management of recent onset Crohn's disease: a controlled, randomized trial comparing step-up and top-down therapy. Gastroenterology. 2005; 129: 370.
  • 10
    Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005; 128: 862–869.
View Full Article (HTML) Get PDF (98K)